Literature DB >> 12625959

Application and limitations of chloromethyl-benzamidodialkylcarbocyanine for tracing cells used in bone Tissue engineering.

M C Kruyt1, J De Bruijn, M Veenhof, F C Oner, C A Van Blitterswijk, A J Verbout, W J A Dhert.   

Abstract

Bone tissue engineering has the potential to provide us with an autologous bone substitute. Despite extensive research to optimize the technique, little is known about the survival and function of the cells after implantation. To monitor the cells, in vivo labeling is the method of choice. In this study we investigated the use of the fluorescent membrane marker chloromethyl-benzamidodialkylcarbocyanine (CM-Dil) to label cells used in bone tissue engineering. When applying label concentrations up to 50 microM, cells could be labeled efficiently without negative effects on cell vitality, proliferation, or bone-forming capacity. Porous hydroxyapatite scaffolds were seeded with labeled cells, and up to 6 weeks after implantation in nude mice cells could be traced inside tissue-engineered bone. However, contrary to other reports concerning intramembranous labels, transfer of the label from labeled to unlabeled cells was detected. Transfer occurred both in vitro and in vivo between vital cells and between dead and living cells. To determine when in vivo label transfer happened, devitalized, labeled constructs were implanted for various time periods in nude mice. The presence of vital labeled cells inside these constructs, when evaluated at different implantation periods, indicated transfer of the label. Transfer occurred at 7 days postimplantation when 40 microM label was applied, whereas 10 microM labeled constructs showed transfer 10 days after implantation. These findings indicate that CM-Dil label is useful for in vivo tracing of cells for follow-up periods up to 10 days. This makes the label particularly useful for cell survival studies in tissue-engineered implants.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12625959     DOI: 10.1089/107632703762687582

Source DB:  PubMed          Journal:  Tissue Eng        ISSN: 1076-3279


  12 in total

1.  Umbilical cord-derived mesenchymal stem cells regulate thymic epithelial cell development and function in Foxn1(-/-) mice.

Authors:  Guangyang Liu; Lihua Wang; Tianxiang Pang; Delin Zhu; Yi Xu; Hanyu Wang; Xiuli Cong; Yongjun Liu
Journal:  Cell Mol Immunol       Date:  2014-02-24       Impact factor: 11.530

2.  Angioneural crosstalk in scaffolds with oriented microchannels for regenerative spinal cord injury repair.

Authors:  Aybike Saglam; Anat Perets; Adam Charles Canver; Ho-Lung Li; Katherine Kollins; Gadi Cohen; Itzhak Fischer; Philip Lazarovici; Peter I Lelkes
Journal:  J Mol Neurosci       Date:  2012-08-10       Impact factor: 3.444

3.  Angiogenic and osteogenic regeneration in rats via calcium phosphate scaffold and endothelial cell co-culture with human bone marrow mesenchymal stem cells (MSCs), human umbilical cord MSCs, human induced pluripotent stem cell-derived MSCs and human embryonic stem cell-derived MSCs.

Authors:  Wenchuan Chen; Xian Liu; Qianmin Chen; Chongyun Bao; Liang Zhao; Zhimin Zhu; Hockin H K Xu
Journal:  J Tissue Eng Regen Med       Date:  2017-06-13       Impact factor: 3.963

4.  An avian model for the reversal of neurobehavioral teratogenicity with neural stem cells.

Authors:  Sharon Dotan; Adi Pinkas; Theodore A Slotkin; Joseph Yanai
Journal:  Neurotoxicol Teratol       Date:  2010-03-04       Impact factor: 3.763

Review 5.  Stem cell therapy for erectile dysfunction: a critical review.

Authors:  Ching-Shwun Lin; Zhong-Cheng Xin; Zhong Wang; Chunhua Deng; Yun-Ching Huang; Guiting Lin; Tom F Lue
Journal:  Stem Cells Dev       Date:  2011-09-07       Impact factor: 3.272

Review 6.  Commonly used mesenchymal stem cell markers and tracking labels: Limitations and challenges.

Authors:  Ching-Shwun Lin; Zhong-Cheng Xin; Jican Dai; Tom F Lue
Journal:  Histol Histopathol       Date:  2013-04-16       Impact factor: 2.303

7.  Fibrin-mediated delivery of an ovarian follicle pool in a mouse model of infertility.

Authors:  Rachel M Smith; Ariella Shikanov; Ekaterina Kniazeva; Deepa Ramadurai; Teresa K Woodruff; Lonnie D Shea
Journal:  Tissue Eng Part A       Date:  2014-06-12       Impact factor: 3.845

8.  Intra-articular delivery of purified mesenchymal stem cells from C57BL/6 or MRL/MpJ superhealer mice prevents posttraumatic arthritis.

Authors:  Brian O Diekman; Chia-Lung Wu; Craig R Louer; Bridgette D Furman; Janet L Huebner; Virginia B Kraus; Steven A Olson; Farshid Guilak
Journal:  Cell Transplant       Date:  2012-08-10       Impact factor: 4.064

9.  Reversal of chlorpyrifos neurobehavioral teratogenicity in mice by nicotine administration and neural stem cell transplantation.

Authors:  Hana Billauer-Haimovitch; Theodore A Slotkin; Sharon Dotan; Rachel Langford; Adi Pinkas; Joseph Yanai
Journal:  Behav Brain Res       Date:  2009-08-12       Impact factor: 3.332

10.  Combining mesenchymal stem cell sheets with platelet-rich plasma gel/calcium phosphate particles: a novel strategy to promote bone regeneration.

Authors:  Yiying Qi; Lie Niu; Tengfei Zhao; Zhongli Shi; Tuoyu Di; Gang Feng; Junhua Li; Zhongming Huang
Journal:  Stem Cell Res Ther       Date:  2015-12-21       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.